CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer
Clinical trial NCT01964378 · TERMINATED
Trial details
- NCT number
- NCT01964378
- Sponsor
- Tris Pharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-29
- Primary completion
- 2015-10-16
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.